Eagle Global Advisors LLC Takeda Pharmaceutical CO LTD Transaction History

Eagle Global Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 15, 2021	SELL	$16.55 - $18.64 $2.6 Million - $2.92 Million	-156,897 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$16.71 - $19.9 $61,643 - $73,411	-3,689 Reduced 2.3%	156,897 $2.87 Million
Q4 2020 Feb 01, 2021	SELL	$15.39 - $18.97 $163,380 - $201,385	-10,616 Reduced 6.2%	160,586 $2.92 Million
Q3 2020 Oct 22, 2020	SELL	$17.1 - $19.19 $25,872 - $29,034	-1,513 Reduced 0.88%	171,202 $3.05 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $98,467 - $131,605	-6,749 Reduced 3.76%	172,715 $3.1 Million
Q1 2020 May 06, 2020	SELL	$13.02 - $20.31 $105,475 - $164,531	-8,101 Reduced 4.32%	179,464 $2.72 Million
Q4 2019 Feb 06, 2020	BUY	$16.88 - $20.83 $1.1 Million - $1.36 Million	65,125 Added 53.19%	187,565 $3.7 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $227,779 - $253,730	-14,104 Reduced 10.33%	122,440 $2.11 Million
Q2 2019 Aug 13, 2019	BUY	$16.58 - $20.49 $528,437 - $653,057	31,872 Added 30.45%	136,544 $2.42 Million
Q1 2019 Apr 22, 2019	BUY	$16.7 - $21.52 $1.75 Million - $2.25 Million	104,672 New	104,672 $2.13 Million

319

70.3M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Global Advisors LLC with notifications on news.